Pages that link to "Q49369729"
Jump to navigation
Jump to search
The following pages link to Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis. (Q49369729):
Displaying 14 items.
- Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction (Q58791270) (← links)
- YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6 (Q63408561) (← links)
- T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword (Q63915433) (← links)
- Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis (Q64258735) (← links)
- Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment). (Q64914989) (← links)
- Nanoimmunotherapy targeting CD40-TRAF6 signalling to reduce atherosclerosis (Q88538178) (← links)
- Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease (Q89601471) (← links)
- The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease (Q90723624) (← links)
- Nanoimmunotherapy to treat ischaemic heart disease (Q91411240) (← links)
- Nanoparticle Therapy for Vascular Diseases (Q91754431) (← links)
- Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis (Q92703822) (← links)
- Inflammation-targeted vascular nanomedicine (Q92767181) (← links)
- Inflammation in atherosclerotic cardiovascular disease (Q92859238) (← links)
- High density lipoprotein mimicking nanoparticles for atherosclerosis (Q92956685) (← links)